Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ePoster Display

CN19 - BRCA mutation carriers’ and stakeholders’ perspectives on cancer risk management and decision-making: A qualitative study

Date

16 Sep 2021

Session

ePoster Display

Topics

Genetic Testing and Counselling;  Cancer Prevention;  Genetic and Genomic Testing;  Patient Education and Advocacy

Tumour Site

Breast Cancer;  Ovarian Cancer

Presenters

Manria Polus

Citation

Annals of Oncology (2021) 32 (suppl_5): S1261-S1265. 10.1016/annonc/annonc692

Authors

M. Polus1, Y. Hanhauser2, S. McGarrigle3, C. Spillane2, N. Byrne2, G. Prizeman1, A. Drury4, E. Connolly2, A. Brady1

Author affiliations

  • 1 School Of Nursing And Midwifery, Trinity College Dublin, D2 - Dublin/IE
  • 2 Breast Care Department, St. James's Hospital, D08 NHY1 - Dublin/IE
  • 3 School Of Nursing And Midwifery, Trinity College Dublin, Dublin/IE
  • 4 School Of Nursing, Midwifery And Health Systems, University College Dublin, D04 V1W8 - Dublin/IE

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract CN19

Background

Women with BRCA+ gene mutation require relevant information to help them to make informed decisions about managing their cancer risk. However, there is a lack of targeted informational support for women living with BRCA+ in Ireland. The objective of this study is to identify the information needs of women with BRCA+ gene mutation regarding cancer risk management and decision-making.

Methods

This is a descriptive qualitative study. Semi structured focus groups and interviews were conducted with female BRCA mutation carriers (n=16) and health and advocacy professionals (n=10). Data were analysed thematically.

Results

Several themes were identified, one of which ‘Cancer Risk Management Decision-Making’ is described herein. Women’s decisions about risk-reducing surgery were affected by their family history, age, level of risk, and plans of having children. Many women found it difficult to decide between mastectomy and screening and choose the timing of oophorectomy. They hoped to receive more information about options for cancer risk management, including surgery, screening, and lifestyle changes.

Conclusions

This study suggests women with a BRCA+ gene mutation need more accessible information about the decision-making process and risk management options. The results will be used to identify relevant content for developing an informational decision aid.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

The authors.

Funding

The Irish Cancer Society.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.